Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.
about
Novel platform technology for modular mucosal vaccine that protects against streptococcus.Design of nanomaterial based systems for novel vaccine development.Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite.Intranasal delivery of nanoparticle-based vaccines.Linear and branched polyacrylates as a delivery platform for peptide-based vaccines.Self-assembling lipopeptides with a potent activity against Gram-positive bacteria, including multidrug resistant strains.
P2860
Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Group A Streptococcal vaccine ...... nteraction and immunogenicity.
@en
type
label
Group A Streptococcal vaccine ...... nteraction and immunogenicity.
@en
prefLabel
Group A Streptococcal vaccine ...... nteraction and immunogenicity.
@en
P2093
P2860
P50
P356
P1433
P1476
Group A Streptococcal vaccine ...... nteraction and immunogenicity.
@en
P2093
Ashwini K Giddam
Mehfuz Zaman
Michael R Batzloff
Saranya Chandrudu
Virginia McPhun
P2860
P304
P356
10.2217/NNM.14.190
P577
2014-12-01T00:00:00Z